CN103271961B - Preparation for treating rheumatic bone diseases - Google Patents
Preparation for treating rheumatic bone diseases Download PDFInfo
- Publication number
- CN103271961B CN103271961B CN201310233315.6A CN201310233315A CN103271961B CN 103271961 B CN103271961 B CN 103271961B CN 201310233315 A CN201310233315 A CN 201310233315A CN 103271961 B CN103271961 B CN 103271961B
- Authority
- CN
- China
- Prior art keywords
- parts
- pharmaceutical composition
- grams
- preparation
- bone diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a preparation for treating rheumatic bone diseases. The preparation comprises a first pharmaceutical composition and a second pharmaceutical composition, wherein the first pharmaceutical composition comprises substances in parts by weight as follows: realgar, Chinese blister beetles and asarum; and the second pharmaceutical composition comprises substances in parts by weight as follows: pearls, borneol, cinnabar and pseudo-ginseng. The preparation for treating the rheumatic bone diseases has the characteristics that the preparation is low in cost, easy to prepare, insignificant in toxic and side effects and remarkable in curative effect.
Description
Technical field
The present invention relates to tcm field, specifically, relate to a kind of medicament for the treatment of rheumatic osteopathia.
Background technology
The various rheumatism such as neck-shoulder pain, lumbago and leg pain and osteoarthritis are the diseases that has a strong impact on human health and quality of life.In recent years, be the trend of increasing year by year, and brought great misery and worry to patient's live and work, also brought endless disaster to family.Rheumatic osteopathia comprises each osteoarthrosis rheumatic arthritis, each hyperosteogenies such as neck, waist, knee joint, and cervical vertebra, lumbar intervertebral disc are deviate from and scapulohumeral periarthritis etc.
Summary of the invention
The object of this invention is to provide a kind of medicament for the treatment of rheumatic osteopathia.
In order to realize object of the present invention, the invention provides a kind of medicament for the treatment of rheumatic osteopathia, it comprises:
The first pharmaceutical composition, it is to be made up of the material of following weight proportioning: Realgar 8-12 part, Mylabris 20-30 part and Herba Asari 3-5 part; And
The second pharmaceutical composition, it is to be made up of the material of following weight proportioning: Margarita 10-20 part, Borneolum Syntheticum 5-10 part, Cinnabaris 50-100 part and Radix Notoginseng 100-200 part.
Preferably, the kit for the treatment of rheumatic osteopathia of the present invention contains:
The first pharmaceutical composition, it is to be made up of the material of following weight proportioning: 5 parts of 10 parts of Realgars, 25 parts of Mylabris and Herba Asaris; And
The second pharmaceutical composition, it is to be made up of the material of following weight proportioning: 150 parts of 15 parts of Margaritas, 8 parts of Borneolum Syntheticums, 70 parts, Cinnabaris and Radix Notoginseng.
More preferably, the medicament for the treatment of rheumatic osteopathia of the present invention also comprises the 3rd pharmaceutical composition, and it is to be made up of the material of following weight proportioning: 5 parts of 5 parts of Fructus Broussonetiaes, 6 parts of 3 parts of, Herba Thlaspiss of RADIX PEUCEDANI, 5 parts of Rhizoma Smilacis Chinensiss, 7 parts of Herba Cichoriis, Rhizoma Dioscoreae Septemlobae 46 parts of Fen, Herba Siegesbeckiaes, 3 parts of Herba Gendarussaes, 5 parts of Cortex Syingae Amurensiss, 3 parts of Herba pterocephali, 3 parts of Nodus Nelumbinis Rhizomatis, 7 parts of Medulla Stachyuri (Medulla Helwingiae)s, 4 parts of Flos Bombacis Malabaricis, 5 parts of Concha Arcaes, 3 parts of Caulis Mahoniaes, 6 parts of Folium Sauropis, 7 parts of Semen Lablab Albums, 3 parts of Retinervus Luffae Fructuss, 5 parts of Herba Polygoni cymosis, 3 parts of Semen Celosiae and Fructus Litseae.
More preferably, described the first pharmaceutical composition, the second pharmaceutical composition and the 3rd pharmaceutical composition can be unguentum.
The medicament for the treatment of rheumatic osteopathia of the present invention has the advantages that cost is low, preparation is easy, toxic and side effects is little, curative effect is showing.
Detailed description of the invention
Embodiment 1:
Take 50 grams of 100 grams of Realgars, 250 grams of Mylabris and Herba Asaris, pulverize, cross 80 mesh sieves, add 60 grams, vaseline, stir, thereby obtain the unguentum of the first pharmaceutical composition.
Take 1500 grams of 150 grams of Margaritas, 80 grams of Borneolum Syntheticums, 700 grams, Cinnabaris and Radix Notoginseng, pulverize, cross 80 mesh sieves, add 130 grams, vaseline, stir, thereby obtain the unguentum of the second pharmaceutical composition.
Take 50 grams of 50 grams of Fructus Broussonetiaes, 60 grams of 30 grams of, Herba Thlaspiss of RADIX PEUCEDANI, 50 grams of Rhizoma Smilacis Chinensiss, 70 grams of Herba Cichoriis, Rhizoma Dioscoreae Septemlobae 40 60 grams of Ke, Herba Siegesbeckiaes, 30 grams of Herba Gendarussaes, 50 grams of Cortex Syingae Amurensiss, 30 grams of Herba pterocephali, 30 grams of Nodus Nelumbinis Rhizomatis, 70 grams of Medulla Stachyuri (Medulla Helwingiae)s, 40 grams of Flos Bombacis Malabaricis, 50 grams of Concha Arcaes, 30 grams of Caulis Mahoniaes, 60 grams of Folium Sauropis, 70 grams of Semen Lablab Albums, 30 grams of Retinervus Luffae Fructuss, 50 grams of Herba Polygoni cymosis, 30 grams of Semen Celosiae and Fructus Litseae, pulverize, cross 80 mesh sieves, add 160 grams, vaseline, stir, thereby obtain the unguentum of the 3rd pharmaceutical composition.
Experimental example
Diagnostic criteria
Western medicine diagnose standard is tamed and dociled " surgery " with reference to yellow family, judges according to medical history, sign, conventional roentgenogram and CT examination.Tcm diagnosis standard is with reference to Tibetan medicine's Four-Volume Medical Code.
Choose the 50 routine patients that meet above-mentioned standard, at 19 years old-75 years old age, wherein male accounts for 30 examples, and women accounts for 20 examples.Cervical spondylosis 10 examples, lumbar vertebra hyperosteogeny 15 examples, lumbar vertebra hyperosteogeny merges de-3 examples of waist, de-10 examples of simple waist, knee joint hyperosteogeny 5 examples, scapulohumeral periarthritis 4 examples, with hyperosteogeny 3 examples.Be divided into two groups, every group of 25 routine patients, two groups are compared there was no significant difference (P > 0.05) in sides such as sex, age, the course of disease, state of an illness scorings, have comparability.
First group of patient treats twice every day, the unguentum of the first pharmaceutical composition first making in sore place or affected part coating embodiment 1, and 200 grams of every place coatings, and coating is evenly.After 12 hours, the unguentum of the second pharmaceutical composition making in sore place or affected part coating embodiment 1,200 grams of every place coatings, and coating is evenly.So treatment 1 month.
Second group of patient treats twice every day, the unguentum of the first pharmaceutical composition first making in sore place or affected part coating embodiment 1, and 200 grams of every place coatings, and coating is evenly.After 12 hours, the unguentum of the second pharmaceutical composition making in sore place or affected part coating embodiment 1,200 grams of every place coatings, then, continue the unguentum of the 3rd pharmaceutical composition making in sore place or affected part coating embodiment 1,200 grams of every place coatings, and all coating is even.So treatment 1 month.
Criterion of therapeutical effect
Recovery from illness: clinical symptom disappearance, limb activity freely, is taken care of oneself.Effective: clinical symptoms disappears substantially, limb activity freely, can substantially take care of oneself by life.Invalid: with treatment before be not improved.
Therapeutic outcome
In first group of patient, recovery from illness 15 examples, effective 10 examples; In second group of patient, recovery from illness 25 examples.In observation, do not occur serious adverse reaction, after treatment finishes, two groups of patients' blood, urine, stool routine and hepatic and renal function inspection are showed no extremely.
Claims (2)
1. treat a medicament for rheumatic osteopathia, it is characterized in that it is made up of following composition:
The first pharmaceutical composition, it is to be made up of the material of following weight proportioning: Realgar 8-12 part, Mylabris 20-30 part and Herba Asari 3-5 part; And
The second pharmaceutical composition, it is to be made up of the material of following weight proportioning: Margarita 10-20 part, Borneolum Syntheticum 5-10 part, Cinnabaris 50-100 part and Radix Notoginseng 100-200 part,
Described the first pharmaceutical composition and described the second pharmaceutical composition are unguentum.
2. the medicament for the treatment of rheumatic osteopathia according to claim 1, is characterized in that it is made up of following composition:
The first pharmaceutical composition, it is to be made up of the material of following weight proportioning: 5 parts of 10 parts of Realgars, 25 parts of Mylabris and Herba Asaris; And
The second pharmaceutical composition, it is to be made up of the material of following weight proportioning: 150 parts of 15 parts of Margaritas, 8 parts of Borneolum Syntheticums, 70 parts, Cinnabaris and Radix Notoginseng.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310233315.6A CN103271961B (en) | 2013-06-14 | 2013-06-14 | Preparation for treating rheumatic bone diseases |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310233315.6A CN103271961B (en) | 2013-06-14 | 2013-06-14 | Preparation for treating rheumatic bone diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103271961A CN103271961A (en) | 2013-09-04 |
| CN103271961B true CN103271961B (en) | 2014-08-06 |
Family
ID=49054209
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310233315.6A Expired - Fee Related CN103271961B (en) | 2013-06-14 | 2013-06-14 | Preparation for treating rheumatic bone diseases |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103271961B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104306600A (en) * | 2014-09-28 | 2015-01-28 | 苏州市天灵中药饮片有限公司 | Plaster for treating rheumatoid bone diseases and preparation method of plaster |
| CN106390131A (en) * | 2016-11-30 | 2017-02-15 | 郑州仁宏医药科技有限公司 | Western medicine composition for treating rheumatic bone disease |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1720938A (en) * | 2005-07-14 | 2006-01-18 | 陈明东 | Medicine for treating rheumatic arthritis and ankylosing spondylitis and its preparing process |
| CN101543582A (en) * | 2008-03-24 | 2009-09-30 | 王宝岭 | Chinese medicinal ointment for treating osteopathy |
| CN101658614A (en) * | 2008-08-28 | 2010-03-03 | 天津市中宝制药有限公司 | Chinese medicinal composition for treating multiple kinds of arthritis |
-
2013
- 2013-06-14 CN CN201310233315.6A patent/CN103271961B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1720938A (en) * | 2005-07-14 | 2006-01-18 | 陈明东 | Medicine for treating rheumatic arthritis and ankylosing spondylitis and its preparing process |
| CN101543582A (en) * | 2008-03-24 | 2009-09-30 | 王宝岭 | Chinese medicinal ointment for treating osteopathy |
| CN101658614A (en) * | 2008-08-28 | 2010-03-03 | 天津市中宝制药有限公司 | Chinese medicinal composition for treating multiple kinds of arthritis |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103271961A (en) | 2013-09-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100560119C (en) | A kind of externally applied ointment of activating blood circulation and unblocking obstruction | |
| CN103520698A (en) | Drug used for treating dysmenorrhea | |
| CN104587090A (en) | Medicine for treating rheumatoid arthritis | |
| CN102091289B (en) | Traditional Chinese medicine preparation for treating acute and chronic soft tissue injuries | |
| CN104398982A (en) | Traditional Chinese medicine composition for treating traumatic injury and joint pain and swelling | |
| CN103271961B (en) | Preparation for treating rheumatic bone diseases | |
| CN101912536B (en) | Medicinal composition for treating rheumatism and rheumatoid disease | |
| CN114588242B (en) | Pharmaceutical composition for treating rheumatoid arthritis | |
| CN104288252A (en) | Drug for treating arthralgia | |
| CN104107288A (en) | Sinew-relaxing collateral-activating pill | |
| CN102552843B (en) | Medicament composite for curing osteoarthropathy | |
| CN103948878B (en) | A kind of Chinese medicine composition for the treatment of osteopathia | |
| CN102430096B (en) | Medicament for treating rheumatic or rheumatoid diseases | |
| CN105853902A (en) | Plaster for treating lumbar disc herniation and preparation method thereof | |
| CN104623476A (en) | Traditional Chinese medicine composition for treating osteoproliferation | |
| CN102836346B (en) | Traditional Chinese medicine for treating lumbar disc herniation | |
| CN102283942A (en) | Orally-administrated Chinese medicinal preparation for treating ankylosing spondlitis | |
| CN102552823A (en) | Medicine for treating osteoarthritis and preparation method thereof | |
| CN105641191A (en) | Orally-taken medicine for treating fracture and soft tissue contusion at preliminary stage | |
| CN102961727B (en) | Traditional Chinese medicine composition for treating bone diseases in clinical nursing | |
| CN105688096A (en) | Traditional Chinese medicine composition for treating gout | |
| CN104001031A (en) | Medicament for treating asthma | |
| CN105250641A (en) | Traditional Chinese medicine composition for treating rheumatism | |
| CN103520671B (en) | Preparation method of medicament for treating traumatic injury | |
| CN115624582A (en) | Novel prescription for treating knee pain and preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140806 Termination date: 20150614 |
|
| EXPY | Termination of patent right or utility model |